Results 11 to 20 of about 7,279 (128)

The efficacy of the application of the curative criteria of the 5rd edition Japanese gastric cancer treatment guidelines for early adenocarcinoma of the esophagogastric junction treated by endoscopic submucosal dissection

The Saudi Journal of Gastroenterology, 2021
Background: The curative criteria after endoscopic submucosal dissection for early gastric carcinoma were updated by the Japanese Gastric Cancer Association.
Zhihao Chen, Yong Liu, Lizhou Dou, Yueming Zhang, Shun He, Guiqi Wang   +5 more
doaj   +1 more source

A long-term survivor of recurrent esophagogastric junction adenocarcinoma treated with multidisciplinary therapy: a case report

Surgical Case Reports, 2020
Background Patients with esophagogastric junction cancer are increasing in Western and Eastern countries. Conversely, the clinical significance of surgical resection remains controversial in these patients.
Takako Tanaka, Takaaki Arigami, Yoshikazu Uenosono, Shigehiro Yanagita, Daisuke Matsushita, Keishi Okubo, Takashi Kijima, Yasuto Uchikado, Yoshiaki Kita, Shinichiro Mori, Ken Sasaki, Itaru Omoto, Hiroshi Kurahara, Kosei Maemura, Sumiya Ishigami, Shoji Natsugoe   +15 more
doaj   +1 more source

Study protocol of a randomized phase III trial of comparing preoperative chemoradiation with preoperative chemotherapy in patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma: PREACT

BMC Cancer, 2019
Background The prognosis of patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma is still dismal. There are no standard treatment strategies for these patients.
Xiaowen Liu, Jiejie Jin, Hong Cai, Hua Huang, Guangfa Zhao, Ye Zhou, Jianghong Wu, Chunyan Du, Ziwen Long, Yantian Fang, Mingze Ma, Guichao Li, Menglong Zhou, Jiliang Yin, Xiaodong Zhu, Ji zhu, Weiqi Sheng, Dan Huang, Hui Zhu, Zhaozhen Zhang, Qi Lu, Li Xie, Zhen Zhang, Yanong Wang   +23 more
doaj   +1 more source

A unique case of esophageal carcinosarcoma with histopathological diversities

Human Pathology: Case Reports, 2019
We report a 57-year-old Japanese male with esophageal carcinosarcoma with histopathological diversities. The patient complained of dysphagia.
Shohei Matsuo, MD, Yoshiki Nakamura, MD, PhD, Motoki Hiroyoshi, MD, PhD, Ken-ichi Tomiyama, MD, PhD, Terumasa Sashikata, MD, PhD, Nobuyuki Kondo, MD, PhD, Yoshitane Tsukamoto, MD, PhD   +6 more
doaj   +1 more source

Renal cell carcinoma metastasizing to adenocarcinoma of esophagogastric junction: A rare case of tumor-to-tumor metastasis

Indian Journal of Pathology and Microbiology, 2012
The simultaneous occurrence of two primary tumors in one patient is not uncommon, but one tumor metastasizing to another malignancy is a rare phenomenon. Tumor-to-tumor metastasis was first described by Berent in 1902.
Renu Sukumaran, Anitha Mathews, Thara Somanathan, Jayasree Kattoor   +3 more
doaj   +1 more source

Cervical metastasis of esophagogastric junction cancer

Indian Journal of Pathology and Microbiology, 2012
As cervical metastases in esophagogastric junction cancer are extremely rare, the authors herein report a case. A 63-year-old woman presented with dysphagia since 6 months.
Zhiqiang Cai, Xiaoyan Shu, Junchuan Li, Jiyuan Yang   +3 more
doaj   +1 more source

How to decide surgical procedure for esophagogastric junction cancer? [PDF]

Клиническая практика, 2020
Standard surgical procedure for esophagogastric junction cancer, especially adenocarcinoma, has still remained controversial. Various procedures has been allowed and applied for Siewert type II tumors.
Yasuyuki Seto, Hiroharu Yamashita
doaj   +1 more source

Application of preoperative endoscopic ultrasonography-guided carbon nanoparticle tattooing combined with titanium clip labeling in esophagogastric junction adenocarcinoma

The Turkish Journal of Gastroenterology, 2019
Cite this article as: Lin L, Wang M, Hong J, Yang S, Wang Y. Application of preoperative endoscopic ultrasonography-guided carbon nanoparticle tattooing combined with titanium clip labeling in esophagogastric junction adenocarcinoma. Turk J Gastroenterol
Lan Lin, Ming Wang, Jie Hong, Sheng Yang, Yu Wang   +4 more
doaj   +1 more source

Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction

World Journal of Surgical Oncology, 2012
Background The epidermal growth factor receptor (EGFR) inhibitor, gefitinib, has been reported to successfully treat advanced non-small cell lung cancer patients with genetic mutations in EGFR.
Wang Wen-Ping, Wang Kang-Ning, Gao Qiang, Chen Long-Qi   +3 more
doaj   +1 more source

Multidisciplinary Treatment for Esophagogastric Junction Cancer From a Dutch Perspective. [PDF]

Ann Gastroenterol Surg
ABSTRACT Esophagogastric junction (EGJ) cancer is an increasing health burden worldwide. Over the past decade, significant advancements in centralization, multimodal treatment strategies, as well as the widespread adoption of minimally invasive surgical techniques, have led to marked improvements in perioperative outcomes and overall survival of EGJ ...
Overtoom HCG, Gisbertz SS.
europepmc   +2 more sources